The Pandemic Remade Everything — Including Smoking
The Pandemic Remade Everything — Including Smoking
New research led by associate professor Lucy Popova examines how the COVID-19 pandemic affected tobacco use in America.


New research led by associate professor Lucy Popova examines how the COVID-19 pandemic affected tobacco use in America.

What does a Georgia State University online graduate nursing student look like? He might look like Semere Araya, the son of immigrants from Eritrea, who juggles a demanding job, family responsibilities and the dream of influencing future nursing students.

Health & Wellness, Politics, Law & Society
Law professor Erin Fuse Brown studies the many ways in which Americans are ill-served by the nation’s healthcare system. But change could be on the horizon.

The first-of-its-kind study reveals new information about the relationship between neuron activity and blood flow deep in the brain, as well as how the brain is affected by salt consumption.

To better reach outpatients early after a COVID-19, infection, Gilead Sciences Inc. has partnered with researchers in Georgia State University’s Center for Translational Antiviral Research to test a modified version of remdesivir that can be taken orally.

A new research center led by Richard Plemper in the Institute for Biomedical Sciences will develop critical antiviral drugs to meet the challenge of existing and newly evolving threats, such as coronaviruses.

Professor Christopher Basler has spent his career stalking Ebola, and recently he hit upon a surprising discovery that could suggest new ways to treat the deadly infection.

Caroline Williams earned her Ph.D. in Translational Biomedical Sciences by embarking upon studies of two newly emerging viruses, SARS-CoV-2, the virus that causes COVID-19, and Mengla virus, a newly identified filovirus.

The training will emphasize new trauma-informed approaches and reducing the use of antipsychotic drugs to manage residents’ symptoms.

A new cancer treatment co-developed by associate professor Maged Henary is one of the first Georgia State-based technologies to enter clinical trials.